ESR1 and cancer: Our study provides another direction in the clinical use of ESR1 gene: the presence of cancer-specific ESR1 circular isoforms, instead of estrogen receptor 1 protein levels or transcript abundance, might be a potential biomarker for EC diagnosis and progression.